Food and Drug Administration Commissioner Dr. Margaret Hamburg dropped by Philadelphia Tuesday for the Pennsylvania Bio’s Life Sciences Future conference. She said the federal agency is making progress with its efforts to accelerate the drug and device approval process — while noting more work needs to be done.
Hamburg said the agency’s challenge is to preserve its standards for ensuring that new medical products are safe and effective while at the same time providing a way for patients to get access to new therapies and medical technology as early as possible.
After taking office in 2009, one of her first goals was to provide "greater clarity and predictability" around the FDA's regulatory pathway. “We’ve worked hard on that," she said. "There’s more work to be done. Part of that has been to make more information available about what we do and how we do it.” Read full story here
For more business news, head to PBJ.com
